#Japan #Tokyo #AI Sakura #Koyama Clinic #Tifana Dotcom

AI Agent 'Sakura' Revolutionizing Patient Interaction at Koyama Central Clinic

The Koyama Central Clinic, located near Musashi-Koyama station in Shinagawa, Tokyo, has recently announced the implementation of its AI reception agent, 'Sakura', provided by Tifana Dotcom Co., Ltd. This advanced AI system is set to roll out on April 17, 2025, and aims to improve how the clinic interacts with its patients.

A Community-Centric Clinic

Koyama Central Clinic specializes in internal medicine and gastroenterology, serving as a family doctor's clinic for the local community. Its dedicated staff caters to a diverse patient demographic, ranging from children to the elderly. The clinic prioritizes providing warm and considerate healthcare services, contributing significantly to the well-being of local residents.

The Need for Digital Transformation

As the demand for healthcare services increases, the clinic faces challenges in managing patient interactions efficiently. Receptionists often juggle multiple responsibilities, including answering phones and performing administrative tasks while assisting visiting patients. This workload has increased, especially as patients frequently inquire about nearby hospitals and the use of the clinic's application. Such distractions can take staff away from their primary duties, which can detract from the overall patient experience.

To address these challenges, Koyama Central Clinic has embraced digital transformation through AI 'Sakura'. By delegating routine inquiries and tasks to the AI agent, the clinic hopes to streamline operations and enhance patient responsiveness.

Features of AI 'Sakura'

Installed at the clinic’s reception, AI 'Sakura' will handle various tasks:

• - Providing information on consultation hours and health checkups.
• - Offering guidance to nearby hospitals, clinics, and pharmacies.
• - Explaining how to install and use the appointment application.
• - Delivering visual aids through instructional videos.

AI 'Sakura' is designed to engage with patients warmly and effectively, much like a human receptionist would. Utilizing the latest generative AI technology, it can hold natural conversations tailored to each patient's inquiries or concerns, addressing their feelings of uncertainty or curiosity with empathy.

Through this integration, clinic staff can focus on critical medical duties while ensuring patients experience a smooth and reassuring visit.

Future of Medicine and Technology

Koyama Central Clinic is committed to leveraging state-of-the-art technology to enhance operational efficiency and patient service. The introduction of AI 'Sakura' marks the beginning of a series of digital initiatives aimed at improving healthcare delivery.

What is AI 'Sakura'?

AI 'Sakura' is an innovative AI system that allows users to utilize sophisticated features without the need for extensive setup or tuning.

Why Choose AI 'Sakura'?

• - Equipped with advanced AI technologies, including ChatGPT and image generation.
• - Holds patents in AI-related technologies and complies with various ISO standards for quality assurance and cloud security.
• - Customized swiftly to align with specific client operational needs, with fully automated operation and maintenance tasks.

Many companies pursuing digital transformation are now adopting AI 'Sakura'. It is utilized across various sectors, including transportation, large corporations, municipal governments, and commercial facilities, where it aids in AI-driven customer service and avatar interaction.

Company Overview

Tifana Dotcom Co., Ltd. is headquartered in Meguro, Tokyo, and operates with the mission, 'Creating a world filled with smiles through the power of web and AI.' Established in 2000, the company has focused on web development and has implemented numerous digital solutions. In 2016, they launched AI 'Sakura', which has since been integrated into various enterprises and local municipalities, playing a pivotal role in advancing digital transformation efforts. From March 2024, Tifana will join the HEROZ group, listed on the Tokyo Stock Exchange.

With the rollout of AI 'Sakura', Koyama Central Clinic not only enhances the patient experience but also sets a precedent for the adoption of technology in healthcare, ensuring the future remains bright for both patients and healthcare professionals alike.